HeldPharma is a leading pharmaceutical manufacturer dedicated to producing premium-grade compounds for healthcare professionals and research institutions worldwide. Founded in 2008 in Zurich, Switzerland, we have grown into a trusted partner for medical practitioners across more than 40 countries.
Our Mission
We believe that every patient deserves access to pharmaceutical products of the highest quality. Our mission is to deliver innovative, rigorously tested, and competitively priced compounds that meet the evolving needs of modern healthcare.
From raw material sourcing to final product delivery, every step in our process is guided by an unwavering commitment to excellence and patient safety.
What We Do
HeldPharma manufactures three primary categories of pharmaceutical-grade compounds, each developed to meet the stringent requirements of clinical and therapeutic use:
- Testosterone-Based Products — Various ester formulations designed for sustained release and optimal pharmacokinetic profiles.
- Bulking / Wet Compounds — Therapeutic applications requiring anabolic support, with careful attention to minimizing side effect profiles.
- Cutting / Dry Compounds — Precision-dosed formulations for lean tissue preservation and metabolic enhancement under clinical supervision.
Quality Assurance
Every product that bears the HeldPharma name has passed a rigorous multi-stage quality control process.
- Raw Material Verification — All incoming active pharmaceutical ingredients are tested against reference standards using HPLC and mass spectrometry.
- In-Process Controls — Critical parameters are monitored in real time during manufacturing.
- Finished Product Testing — Each batch is analyzed for identity, assay, sterility, and endotoxin levels before release.
- Stability Studies — Long-term programs ensure product integrity throughout the stated shelf life.
Quality is never an accident. It is always the result of intelligent effort and meticulous execution.
Dr. Marcus Held, Founder & CEO
Our History
| Year | Milestone |
|---|---|
| 2008 | Founded as a compounding pharmacy in Zurich, Switzerland |
| 2012 | Achieved GMP certification for injectable manufacturing |
| 2015 | Expanded to a 12,000 m² production facility |
| 2018 | Launched oral formulation line |
| 2021 | Distribution partnerships in 40+ countries |
| 2024 | Opened new R&D center for peptide synthesis |
Get in Touch
Whether you are a healthcare provider, distributor, or researcher — we would love to hear from you.
HeldPharma AG · Industriestrasse 42 · 8005 Zürich, Switzerland · All products are intended for professional and institutional use only.